Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Omega Therapeutics's share price for the quarter that ended in Mar. 2024 was $3.65. Omega Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 55.16 Mil. Therefore, Omega Therapeutics's market cap for the quarter that ended in Mar. 2024 was $201.32 Mil.
Omega Therapeutics's quarterly market cap
increased
from Sep. 2023 ($118.55 Mil) to Dec. 2023 ($165.99 Mil) and
increased
from Dec. 2023 ($165.99 Mil) to Mar. 2024 ($201.32 Mil).
Omega Therapeutics's annual market cap
declined
from Dec. 2021 ($541.50 Mil) to Dec. 2022 ($274.49 Mil) and
declined
from Dec. 2022 ($274.49 Mil) to Dec. 2023 ($165.99 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Omega Therapeutics's Enterprise Value for Today is $190.58 Mil.
Omega Therapeutics Market Cap Historical Data
The historical data trend for Omega Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Omega Therapeutics's Market Cap
For the Biotechnology subindustry, Omega Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Therapeutics's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Omega Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Omega Therapeutics's Market Cap falls into.
Omega Therapeutics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Omega Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Therapeutics (NAS:OMGA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Omega Therapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of Omega Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Omega Therapeutics (Omega Therapeutics) Business Description
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. It primarily operates in the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OMGA has been successfully added to your 